×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CC – chemours company (the) (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/5
08:45 am
cc
Chemours (CC) had its price target raised by Mizuho from $17.00 to $21.00. They now have an "outperform" rating on the stock.
Low
Report
Chemours (CC) had its price target raised by Mizuho from $17.00 to $21.00. They now have an "outperform" rating on the stock.
3/3
04:03 pm
cc
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
2/28
02:54 pm
cc
The Chemours Company (CC): A Bull Case Theory [Yahoo! Finance]
Low
Report
The Chemours Company (CC): A Bull Case Theory [Yahoo! Finance]
2/26
05:13 pm
cc
The Chemours Company Announces Upsizing and Pricing of Private Offering of $700,000,000 of 7.875% Senior Notes Due 2034 [Yahoo! Finance]
Medium
Report
The Chemours Company Announces Upsizing and Pricing of Private Offering of $700,000,000 of 7.875% Senior Notes Due 2034 [Yahoo! Finance]
2/26
04:39 pm
cc
The Chemours Company Announces Upsizing and Pricing of Private Offering of $700,000,000 of 7.875% Senior Notes Due 2034
Medium
Report
The Chemours Company Announces Upsizing and Pricing of Private Offering of $700,000,000 of 7.875% Senior Notes Due 2034
2/26
03:18 pm
cc
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
2/26
08:58 am
cc
The Chemours Company Announces Private Offering of $600,000,000 of Senior Notes Due 2034
Medium
Report
The Chemours Company Announces Private Offering of $600,000,000 of Senior Notes Due 2034
2/25
11:32 am
cc
Chemours (CC) had its price target raised by The Goldman Sachs Group, Inc. from $14.00 to $18.00. They now have a "neutral" rating on the stock.
Low
Report
Chemours (CC) had its price target raised by The Goldman Sachs Group, Inc. from $14.00 to $18.00. They now have a "neutral" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/3
08:26 pm
cc
Form 4 Chemours Co For: Mar 01 Filed by: Wellman Kristine M
Medium
Report
Form 4 Chemours Co For: Mar 01 Filed by: Wellman Kristine M
3/3
08:25 pm
cc
Form 4 Chemours Co For: Mar 01 Filed by: Dignam Denise
Medium
Report
Form 4 Chemours Co For: Mar 01 Filed by: Dignam Denise
3/3
08:25 pm
cc
Form 4 Chemours Co For: Mar 01 Filed by: Familiar Calderon Gerardo
Medium
Report
Form 4 Chemours Co For: Mar 01 Filed by: Familiar Calderon Gerardo
3/3
08:24 pm
cc
Form 4 Chemours Co For: Mar 02 Filed by: Foley Michael Robert
Medium
Report
Form 4 Chemours Co For: Mar 02 Filed by: Foley Michael Robert
3/3
08:04 pm
cc
Form 4 Chemours Co For: Mar 01 Filed by: Martinko Joseph T.
Medium
Report
Form 4 Chemours Co For: Mar 01 Filed by: Martinko Joseph T.
3/3
08:01 pm
cc
Form 4 Chemours Co For: Mar 01 Filed by: HOSTETTER SHANE
Medium
Report
Form 4 Chemours Co For: Mar 01 Filed by: HOSTETTER SHANE
3/3
07:59 pm
cc
Form 4 Chemours Co For: Mar 01 Filed by: Will David
Medium
Report
Form 4 Chemours Co For: Mar 01 Filed by: Will David
2/26
06:00 pm
cc
Form 4 Chemours Co For: Feb 24 Filed by: Wellman Kristine M
Medium
Report
Form 4 Chemours Co For: Feb 24 Filed by: Wellman Kristine M
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
2/13
Q4/2019 12/31/2019 EPS 0.560 ZacksConsensus 0.430 ActVsEst 0.130 - Beat
23.5%
4/3 Form 8-K Chemours Co For: Apr 03 16.8%
4/9 Chemours Co (NYSE: CC) had its price target lowered by analysts at Citigroup Inc from $10.00 to $8.00. They now have a "neutral" rating on the stock. 15.4%
3/13 Form DEF 14A Chemours Co For: Apr 28 12.7%
12/5 4-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages The Chemours Company (CC) Investors Who Suffered Significant Losses to Contact Its Attorneys: Application Deadline Approaching and Case Now Covers All Publicly Traded Chemours Secu 11.1%
11/4 Q3/2019 9/30/2019 EPS 0.590 ZacksConsensus 0.560 ActVsEst 0.030 - Beat 10.8%
4/28 Chemours Announces Second Quarter Dividend 10.2%
3/25 Chemours Co (NYSE: CC) had its price target lowered by analysts at SunTrust Banks, Inc. from $19.00 to $10.00. They now have a "hold" rating on the stock. 9.1%
10/10 Investor Alert: Kaplan Fox Investigates The Chemours Company 7.1%
9/9 Chemours Co (NYSE: CC) had its price target lowered by analysts at BMO Capital Markets from $31.00 to $23.00. They now have an "outperform" rating on the stock. 6.2%
4/3 Form 8-K Chemours Co For: Apr 03 16.8%
4/9 Chemours Co (NYSE: CC) had its price target lowered by analysts at Citigroup Inc from $10.00 to $8.00. They now have a "neutral" rating on the stock. 15.4%
3/13 Form DEF 14A Chemours Co For: Apr 28 12.7%
12/5 4-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages The Chemours Company (CC) Investors Who Suffered Significant Losses to Contact Its Attorneys: Application Deadline Approaching and Case Now Covers All Publicly Traded Chemours Secu 11.1%
11/4 Q3/2019 9/30/2019 EPS 0.590 ZacksConsensus 0.560 ActVsEst 0.030 - Beat 10.8%
4/28 Chemours Announces Second Quarter Dividend 10.2%
3/25 Chemours Co (NYSE: CC) had its price target lowered by analysts at SunTrust Banks, Inc. from $19.00 to $10.00. They now have a "hold" rating on the stock. 9.1%
10/10 Investor Alert: Kaplan Fox Investigates The Chemours Company 7.1%
9/9 Chemours Co (NYSE: CC) had its price target lowered by analysts at BMO Capital Markets from $31.00 to $23.00. They now have an "outperform" rating on the stock. 6.2%
TOP News Decliners
8/1
Q2/2019 6/30/2019 EPS 0.720 ZacksConsensus 0.890 ActVsEst (0.170) - Miss
-19.1%
3/9 Chemours Inaugurates New World-Class Innovation Center, The Chemours Discovery Hub, on the University of Delaware's Science, Technology and Advanced Research Campus -13.4%
8/2 Chemours Buys Mining Operations Of Southern Ionics Minerals [Reuters] -8.1%
8/8 Form 4 Chemours Co For: Aug 07 Filed by: CRANSTON MARY B -8.0%
5/7 Carrier Transicold Europe Selects Chemours Opteon™ XL Refrigerant Family to Replace R-452A -7.9%
5/6 Chemours Co (NYSE: CC) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. -7.5%
4/15 Chemours Announces Dates for First Quarter 2020 Earnings Release and Webcast Conference Call -7.1%
5/13 The Chemours Company's John Sworen To Be Awarded Gordon E. Moore Medal -6.9%
4/1 Chemours Co (NYSE: CC) had its price target lowered by analysts at Royal Bank of Canada from $13.00 to $11.00. They now have a "sector perform" rating on the stock. -6.4%
9/30 Chemours Renews its Dedication to Sustainability, Issues Second Annual Corporate Responsibility Commitment Report -6.4%
3/9 Chemours Inaugurates New World-Class Innovation Center, The Chemours Discovery Hub, on the University of Delaware's Science, Technology and Advanced Research Campus -13.4%
8/2 Chemours Buys Mining Operations Of Southern Ionics Minerals [Reuters] -8.1%
8/8 Form 4 Chemours Co For: Aug 07 Filed by: CRANSTON MARY B -8.0%
5/7 Carrier Transicold Europe Selects Chemours Opteon™ XL Refrigerant Family to Replace R-452A -7.9%
5/6 Chemours Co (NYSE: CC) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. -7.5%
4/15 Chemours Announces Dates for First Quarter 2020 Earnings Release and Webcast Conference Call -7.1%
5/13 The Chemours Company's John Sworen To Be Awarded Gordon E. Moore Medal -6.9%
4/1 Chemours Co (NYSE: CC) had its price target lowered by analysts at Royal Bank of Canada from $13.00 to $11.00. They now have a "sector perform" rating on the stock. -6.4%
9/30 Chemours Renews its Dedication to Sustainability, Issues Second Annual Corporate Responsibility Commitment Report -6.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: